Sign in
4

Changes in Ownership

KYNTRA BIO, INC. Filed Acc 0001209191-21-015005

Chief Executive Officer acquired 82,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Conterno Enrique A · Chief Executive Officer

Table I: Non-derivative

1 line
Date Transaction Shares Owned after D/I
2021-02-24 Grant or award : show line 1 in the form +82,000 137,273 D

Table II: Derivative

1 line
Date Transaction Shares Exercise Expires Underlying Owned after D/I
2021-02-24 Grant or award : show line 2 in the form Stock Option (Right to Buy) +164,000 $53.01 2031-02-24 164,000 164,000 D
Loading xslF345X03/doc4.xml…